Polyneuropathy: Clinical Trials

1 trial for Polyneuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Polyneuropathy: new trials by email Literature Review of Polyneuropathy trials Research Report on Polyneuropathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
SAB378, methadone, SAB placebo - HIV-associated Neuropathy, Polyneuropathy
Phase 2WithdrawnWashington University School of Medicine2009-04-012018-02-09

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  Marijuana Abuse (1)  ·  Polyneuropathies (1)

Broader conditions

Blood-Borne Infections (1)  ·  Chemically-Induced Disorders (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)

Interventions

Methadone (1)  ·  nabiximols (1)

Sponsors

Washington University School of Medicine (1)

Countries

United States (1)

Top investigators

David B. Clifford, MD (1)

NIH funding

U01NS032228 (1)